Cardiac SARS-CoV-2 infection is associated with distinct transcriptomic changes within the heart
暂无分享,去创建一个
P. Kirchhof | S. Blankenberg | Björn Rotter | D. Westermann | H. Schultheiss | D. Lindner | S. Kluge | B. Stoffers | G. Aleshcheva | T. Huber | F. Escher | A. Fitzek | B. Ondruschka | K. Scherschel | K. Roedl | F. Braun | C. Edler | M. Schweizer | J. Weimann | Hanna Bräuninger | K. Meissner | K. Püschel | S. Warnke | Heinz-Peter-Schultheiss
[1] Silva Kasela,et al. Identification of Required Host Factors for SARS-CoV-2 Infection in Human Cells , 2020, Cell.
[2] Paul J. Hoover,et al. Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patients , 2020, bioRxiv.
[3] S. Goldhaber,et al. Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19 , 2020, Journal of the American College of Cardiology.
[4] Samin K. Sharma,et al. Characterization of Myocardial Injury in Patients With COVID-19 , 2020, Journal of the American College of Cardiology.
[5] R. Malekzadeh,et al. Repurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results , 2020, medRxiv.
[6] F. Heppner,et al. Why misinterpretation of electron micrographs in SARS-CoV-2-infected tissue goes viral , 2020, The Lancet.
[7] B. Conklin,et al. SARS-CoV-2 infection of human iPSC-derived cardiac cells predicts novel cytopathic features in hearts of COVID-19 patients , 2020, bioRxiv.
[8] J. R. Rebello Pinho,et al. SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome , 2020, The Lancet Child & Adolescent Health.
[9] K. Knowlton. Pathogenesis of SARS-CoV-2 induced cardiac injury from the perspective of the virus , 2020, Journal of Molecular and Cellular Cardiology.
[10] Victor G. Puelles,et al. SARS-CoV-2 renal tropism associates with acute kidney injury , 2020, The Lancet.
[11] A. Kurniawan,et al. Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.
[12] P. Kirchhof,et al. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. , 2020, JAMA cardiology.
[13] Eike Nagel,et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.
[14] J. Q. Brown,et al. Unexpected Features of Cardiac Pathology in COVID-19 Infection. , 2020, Circulation.
[15] J. Lacy,et al. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series , 2020, The Lancet.
[16] Nicolas Carlier,et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients , 2020, Science.
[17] H. Krumholz,et al. Extrapulmonary manifestations of COVID-19 , 2020, Nature Medicine.
[18] K. Kotani,et al. COVID‐19—Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] Jennifer L. Bell,et al. Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report , 2020, medRxiv.
[20] C. Hamm,et al. Detection of viral SARS‐CoV‐2 genomes and histopathological changes in endomyocardial biopsies , 2020, ESC heart failure.
[21] M. Aepfelbacher,et al. Dying with SARS-CoV-2 infection—an autopsy study of the first consecutive 80 cases in Hamburg, Germany , 2020, International Journal of Legal Medicine.
[22] A. Frangakis,et al. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes , 2020, bioRxiv.
[23] J. Vincent,et al. Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients , 2020, Critical Care.
[24] R. Claus,et al. Postmortem Examination of Patients With COVID-19. , 2020, JAMA.
[25] Victor G. Puelles,et al. Multiorgan and Renal Tropism of SARS-CoV-2 , 2020, The New England journal of medicine.
[26] Mahmud Arif Pavel,et al. The role of high cholesterol in age-related COVID19 lethality. , 2020, bioRxiv.
[27] K. Mertz,et al. Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction , 2020, Histopathology.
[28] Sara E. Miller,et al. Electron microscopy of SARS-CoV-2: a challenging task , 2020, The Lancet.
[29] M. Hoffmann,et al. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells , 2020, Molecular Cell.
[30] E. Arbustini,et al. Myocardial localization of coronavirus in COVID‐19 cardiogenic shock , 2020, European journal of heart failure.
[31] Tao Guo,et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.
[32] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[33] Susanne Pfefferle,et al. Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[34] Zhifeng Liu,et al. Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort study , 2020, medRxiv.
[35] Victor M Corman,et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[36] Coronavirus Disease 2019 (COVID-19) Daily Situation Report of the Robert Koch Institute , 2020 .
[37] C. Emiliani,et al. The Role of Extracellular Vesicles in Viral Infection and Transmission , 2019, Vaccines.
[38] D. Topham,et al. Novel Functions of IFI44L as a Feedback Regulator of Host Antiviral Responses , 2019, Journal of Virology.
[39] S. Willems,et al. Cardiac glial cells release neurotrophic S100B upon catheter-based treatment of atrial fibrillation , 2019, Science Translational Medicine.
[40] Yukiko Shimizu,et al. TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection , 2019, Journal of Virology.
[41] S. Blankenberg,et al. Precursor proadrenomedullin influences cardiomyocyte survival and local inflammation related to myocardial infarction , 2018, Proceedings of the National Academy of Sciences.
[42] S. Blankenberg,et al. Cardiac Function Remains Impaired Despite Reversible Cardiac Remodeling after Acute Experimental Viral Myocarditis , 2017, Journal of immunology research.
[43] Roland Eils,et al. Complex heatmaps reveal patterns and correlations in multidimensional genomic data , 2016, Bioinform..
[44] Fátima Sánchez-Cabo,et al. GOplot: an R package for visually combining expression data with functional analysis , 2015, Bioinform..
[45] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[46] S. Blankenberg,et al. Cardiac Fibroblasts Aggravate Viral Myocarditis: Cell Specific Coxsackievirus B3 Replication , 2014, Mediators of inflammation.
[47] Sören Müller,et al. APADB: a database for alternative polyadenylation and microRNA regulation events , 2014, Database J. Biol. Databases Curation.
[48] Tiina Heliö,et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.
[49] M. Bouvier,et al. MHC class I antigen presentation: learning from viral evasion strategies , 2009, Nature Reviews Immunology.
[50] E. Rassart,et al. Neuroprotective Effect of Apolipoprotein D against Human Coronavirus OC43-Induced Encephalitis in Mice , 2008, The Journal of Neuroscience.
[51] C. Peyrefitte,et al. Evidence for in vitro falsely-primed cDNAs that prevent specific detection of virus negative strand RNAs in dengue-infected cells: improvement by tagged RT-PCR. , 2003, Journal of virological methods.
[52] T. Fuerst,et al. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. , 1994, Virology.